Archive for Newleos

Newleos Therapeutics Announces Poster Presentation to beFeatured at the 2025 World Congress of BiologicalPsychiatry

September 9, 2025

Newleos Therapeutics Appoints Stephen Brannan to Board of Directors and Announces NTX-1955 Clinical Progress in Generalized Anxiety Disorder

July 24, 2025

Newleos Therapeutics Announces Clinical Advisory Board to Support Key Neuropsychiatry Programs

April 29, 2025

Longwood Fund launches anxiety drug developer with $93.5M investment

February 14, 2025

A brain biotech launches with Roche’s spare parts

February 14, 2025

Newleos Raises $93.5M to Advance Neuropsychiatric Cast-Offs from Roche

February 14, 2025